(Q37207796)

English

Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting

scientific article published on 18 April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Julie Irving

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Jenny Jesson

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Paul Virgo

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Marian Case

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Lynne Minto

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Lisa Eyre

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Nigel Noel

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Ulrika Johansson

8

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Marion Macey

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Linda Knotts

10

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Margaret Helliwell

11

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Paul Davies

12

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Liam Whitby

13

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

David Barnett

14

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Jeremy Hancock

15

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Nick Goulden

16

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Sarah Lawson

17

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

UKALL Flow MRD Group

18

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

UK MRD steering Group

19

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 April 2009

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

94

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

870-874

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

describes a project that uses

1 reference

based on heuristic

inferred from title

CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

6 September 2017

Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

6 September 2017

Minimal residual disease studies in acute leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

6 September 2017

Minimal residual disease studies by flow cytometry in acute leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

6 September 2017

Quality assessment of CD34+ stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

26 June 2018

Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

3 September 2018

Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

3 September 2018

Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

3 September 2018

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

3 September 2018

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

3 September 2018

Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

3 September 2018

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

3 September 2018

Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

3 September 2018

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688581

3 September 2018

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19377076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19377076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19377076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/19377076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping

1 reference

https://pubmed.ncbi.nlm.nih.gov/19377076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of minimal residual disease in acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19377076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19377076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fifty years of studies of the biology and therapy of childhood leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19377076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19377076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR

1 reference

https://pubmed.ncbi.nlm.nih.gov/19377076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19377076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19377076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2008.000414

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37207796&oldid=1877509810"